Search Results

There are 2414 results for: content related to: Lenograstim compared to filgrastim for the mobilization of hematopoietic stem cells in healthy donors

  1. You have free access to this content
    Mobilization and harvesting of peripheral blood stem cells: randomized evaluations of different doses of filgrastim

    British Journal of Haematology

    Volume 100, Issue 2, February 1998, Pages: 338–347, C. H. Weaver, R. Birch, F. A. Greco, L. Schwartzberg, B. McAneny, M. Moore, D. Oviatt, J. Redmond, C. George, T. Alberico, P. Johnson and C. D. Buckner

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1998.00573.x

  2. You have free access to this content
    Retrospective comparison of filgrastim plus plerixafor to other regimens for remobilization after primary mobilization failure: Clinical and economic outcomes

    American Journal of Hematology

    Volume 87, Issue 7, July 2012, Pages: 673–677, Janelle B. Perkins, Jamie F. Shapiro, Ryan N. Bookout, Gary C. Yee, Claudio Anasetti, William E. Janssen and Hugo F. Fernandez

    Version of Record online : 3 JUN 2012, DOI: 10.1002/ajh.23221

  3. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions

    Clinical Pharmacology & Therapeutics

    Volume 66, Issue 4, October 1999, Pages: 415–424, Thomas Hartung, Wolf-Dietrich Doecke, Daniela Bundschuh, MaryAnn Foote, Florian Gantner, Corinna Hermann, Andre Lenz, Steven Milwee, Bill Rich, Bernadett Simon, Hans-Dieter Volk, Sonja von Aulock and Albrecht Wendel

    Version of Record online : 14 OCT 1999, DOI: 10.1053/cp.1999.v66.a101210

  4. Plerixafor as First- and Second-Line Strategies for Autologous Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 32, Issue 7, July 2012, Pages: 596–603, Kevin W. Lor, Pieter J. Helmons, Helen Belew, James R. Lane and Edward D. Ball

    Version of Record online : 3 JUL 2012, DOI: 10.1002/j.1875-9114.2012.01096.x

  5. Collection of two peripheral blood stem cell concentrates from healthy donors

    Transfusion Medicine

    Volume 9, Issue 1, January 1999, Pages: 37–50, Stroncek, Clay, Jaszcz, Lennon, Smith and McCullough

    Version of Record online : 5 JAN 2002, DOI: 10.1046/j.1365-3148.1999.009001037.x

  6. You have free access to this content
    Comparison of two different schedules of granulocyte–colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen


    Volume 94, Issue 2, 15 January 2002, Pages: 285–291, Mary A. Weiser, Susan O'Brien, Deborah A. Thomas, Sherry A. Pierce, Tony P. Lam and Hagop M. Kantarjian

    Version of Record online : 18 JAN 2002, DOI: 10.1002/cncr.10241

  7. Purity assessment of recombinant human granulocyte colony-stimulating factor in finished drug product by capillary zone electrophoresis


    Volume 35, Issue 18, September 2014, Pages: 2608–2614, Goran Benković, Ana Škrlin, Tomislav Madić, Željko Debeljak and Marica Medić-Šarić

    Version of Record online : 1 AUG 2014, DOI: 10.1002/elps.201300552

  8. You have free access to this content
    Granulocyte–colony-stimulating factor (filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase chronic myelogenous leukemia


    Volume 100, Issue 12, 15 June 2004, Pages: 2592–2597, Alfonso Quintas-Cardama, Hagop Kantarjian, Susan O'Brien, Guillermo Garcia-Manero, Mary B. Rios, Moshe Talpaz and Jorge Cortes

    Version of Record online : 7 MAY 2004, DOI: 10.1002/cncr.20285

  9. A pharmacokinetic model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia

    Cell Proliferation

    Volume 42, Issue 6, December 2009, Pages: 813–822, M. Scholz, M. Ackermann, C. Engel, F. Emmrich, M. Loeffler and M. Kamprad

    Version of Record online : 17 AUG 2009, DOI: 10.1111/j.1365-2184.2009.00638.x

  10. Estimating resource use and cost of prophylactic management of neutropenia with filgrastim

    Journal of Nursing Management

    Volume 13, Issue 3, May 2005, Pages: 265–274, L. ANNEMANS, N. VAN OVERBEKE, B. STANDAERT and S. VAN BELLE

    Version of Record online : 7 APR 2005, DOI: 10.1111/j.1365-2834.2005.00550.x

  11. Efficacious and save use of biosimilar filgrastim for hematopoietic progenitor cell chemo-mobilization with vinorelbine in multiple myeloma patients

    Journal of Clinical Apheresis

    Julia-Tatjana Maul, Frank Stenner-Liewen, Burkhardt Seifert, Sarah Pfrommer, Ulf Petrausch, Michael K. Kiessling, Urs Schanz, Gayathri Nair, Axel Mischo, Christian Taverna, Adrian Schmidt, Mario Bargetzi, Roger Stupp, Christoph Renner and Panagiotis Samaras

    Version of Record online : 22 MAR 2016, DOI: 10.1002/jca.21459

  12. You have free access to this content
    review: Current status of stem cell mobilization

    British Journal of Haematology

    Volume 150, Issue 6, September 2010, Pages: 647–662, Morie A. Gertz

    Version of Record online : 2 SEP 2010, DOI: 10.1111/j.1365-2141.2010.08313.x

  13. Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia

    European Journal of Cancer Care

    Volume 13, Issue 4, September 2004, Pages: 371–379, A.-R. WALADKHANI

    Version of Record online : 11 AUG 2004, DOI: 10.1111/j.1365-2354.2004.00503.x

  14. You have full text access to this OnlineOpen article
    A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation

    Archives of Drug Information

    Volume 1, Issue 3, December 2008, Pages: 89–96, Peter Ernst, Andrea Bacigalupo, Olle Ringdén, Tapani Ruutu, Hans J. Kolb, Susan Lawrinson and Tomas Skacel

    Version of Record online : 3 SEP 2008, DOI: 10.1111/j.1753-5174.2008.00013.x

  15. You have free access to this content
    Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-Induced neutropenia


    Volume 115, Issue 20, 15 October 2009, Pages: 4839–4848, Mark L. Heaney, Edmond L. Toy, Francis Vekeman, François Laliberté, Bree L. Dority, Daniel Perlman, Victoria Barghout and Mei Sheng Duh

    Version of Record online : 27 JUL 2009, DOI: 10.1002/cncr.24535

  16. Population Modeling of Filgrastim PK-PD in Healthy Adults Following Intravenous and Subcutaneous Administrations

    The Journal of Clinical Pharmacology

    Volume 50, Issue S9, September 2010, Pages: 101S–112S, Dr Wojciech Krzyzanski, Dr Pawel Wiczling, Dr Phil Lowe, Dr Etienne Pigeolet, Dr Martin Fink, Dr Alexander Berghout and Dr Sigrid Balser

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010376966

  17. Comparison of daily filgrastim and pegfilgrastim to prevent febrile neutropenia in Asian lymphoma patients

    Asia-Pacific Journal of Clinical Oncology

    Volume 7, Issue 1, March 2011, Pages: 75–81, Alexandre CHAN, Xue Zhen LENG, Joen YL CHIANG, Miriam TAO, Richard QUEK, Kevin TAY and Soon Thye LIM

    Version of Record online : 22 DEC 2010, DOI: 10.1111/j.1743-7563.2010.01355.x

  18. A phase II dose finding study of darbepoetin alpha and filgrastim for the management of anaemia and neutropenia in chronic hepatitis C treatment

    Journal of Viral Hepatitis

    Volume 15, Issue 5, May 2008, Pages: 370–378, Z. M. Younossi, F. H. Nader, C. Bai, R. Sjogren, J. P. Ong, R. Collantes, M. Sjogren, D. Farmer, L. Ramsey, K. Terra, H. Gujral, C. Gurung, M. Srishord and Y. Fang

    Version of Record online : 10 JAN 2008, DOI: 10.1111/j.1365-2893.2007.00956.x

  19. Filgrastim versus TBO-filgrastim to reduce the duration of neutropenia after autologous hematopoietic stem cell transplantation: TBO, or not TBO, that is the question

    Clinical Transplantation

    Volume 29, Issue 12, December 2015, Pages: 1128–1132, Steven Trifilio, Zheng Zhou, John Galvin, Jessica L. Fong, Joanne Monreal and Jayesh Mehta

    Version of Record online : 22 OCT 2015, DOI: 10.1111/ctr.12637

  20. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim


    Volume 47, Issue 6, June 2007, Pages: 969–980, Daniel Ribeiro, Marlon R. Veldwijk, Axel Benner, Stephanie Laufs, Frederik Wenz, Anthony D. Ho and Stefan Fruehauf

    Version of Record online : 19 APR 2007, DOI: 10.1111/j.1537-2995.2007.01241.x